Renaissance Technologies - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 28 filers reported holding TENAX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$7
-100.0%
63,362
-55.3%
0.00%
Q3 2022$24,000
+20.0%
141,630
+113.8%
0.00%
Q2 2022$20,000
-63.6%
66,232
-1.8%
0.00%
Q1 2022$55,000
-34.5%
67,432
-16.2%
0.00%
Q4 2021$84,000
-53.8%
80,432
-21.9%
0.00%
Q3 2021$182,000
-54.5%
102,932
-46.5%
0.00%
Q2 2021$400,000
-71.9%
192,232
-74.3%
0.00%
-100.0%
Q1 2021$1,421,000
+79.0%
747,832
+75.1%
0.00%
+100.0%
Q4 2020$794,000
-2.2%
427,032
-19.0%
0.00%0.0%
Q3 2020$812,000
+25.7%
527,352
-26.1%
0.00%0.0%
Q2 2020$646,000
+94.6%
713,452
+22.9%
0.00%
Q1 2020$332,000
-47.5%
580,452
+29.5%
0.00%
Q4 2019$632,000
+28.7%
448,342
+9.5%
0.00%
Q3 2019$491,000
-1.0%
409,541
+13.9%
0.00%
Q2 2019$496,000
+1.4%
359,441
+48.4%
0.00%
Q1 2019$489,000
+145.7%
242,241
+47.0%
0.00%
Q4 2018$199,000
-56.8%
164,741
+87.8%
0.00%
Q3 2018$461,000
-45.1%
87,700
-37.6%
0.00%
Q2 2018$839,000
+168.1%
140,600
+145.8%
0.00%
Q1 2018$313,00057,2000.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,019,995$4,201,0000.08%
FAS Wealth Partners, Inc. 58,326$127,0000.01%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 356,347$742,0000.00%
UBS Group AG 980$2,0000.00%
IFP Advisors, Inc 0$00.00%
Horan Securities, Inc. 1$00.00%
DIMENSIONAL FUND ADVISORS LP 51,895$113,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders